The proteomics industry operates globally and is characterized by its diversity and rapid expansion. As a subset of biotechnology, proteomics focuses on the comprehensive study of proteins, their structures, and functions which are instrumental in the detection and treatment of diseases. The industry is fueled largely by increased R&D investments...
Discover more insightsCurrently, there have been significant expansions in the field of proteasome inhibitors, a pharmaceutically lucrative avenue for targeted therapies. Remarkable developments have taken place in their clinical applicability, especially in oncology and autoimmune disorders. These improvements have presented new opportunities for sufferers across the globe and contribute to the pharmaceutical...
Discover more insightsMetabolomics, the large-scale analysis of small molecules or metabolites within cells, biofluids, tissues, or organisms, forges a critical path in biomedical research. Its pervasive applicability across a range of diseases, drug discovery processes and toxicology studies have catalyzed its growth in the life science sector. Currently, its adoption scale spans...
Discover more insights